More than a year has passed since Humira biosimilars were launched in the US, and with these, severa...
Blog
Use this space to tell everyone about what you have to offer.
We provide a real-world data lab to accelerate the discovery and adoption of healthcare innovations....
PurpleLab’s® Provider Data is the foundation of our simple to use provider data analytics solutions....
This study was run to determine if a racial disparity exists in biomarker testing for NSCLC (non-sma...
PurpleLab’s® Clinical Trial data provides detailed metrics on clinical trial activities performed by...
This study was run to evaluate whether provider specialty is a driver for biosimilar adoption, defin...
PurpleLab® goes further than raw claims data, by serving longitudinal patient data in combination wi...
Glucagon-like peptide-1 (GLP-1) agonists are a class of medications frequently used to treat type 2 ...
Glucagon-like peptide-1 (GLP-1) agonists are a class of medications frequently used to treat type 2 ...
Open claims and closed claims data serve as vital tools for comprehending patients’ progress and eng...